Santen Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally. Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker; and netarsudil mesilate and latanoprost, a prostaglandin F2a derivative which is marketing approval phase for the treatment of glaucoma and ocular hypertension. The company also offers sepetaprost, a p...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 6 7664 8621
Address:
Grand Front Osaka Tower A, 4-20 Ofuka-cho Kita-ku, Osaka, Japan
